Recombinant DNA technology comprises altering genetic material outside an organism to obtain enhanced and desired characteristics in living organisms or as their products. Our unique processes and specialised medical researches ensure we consistently deliver cutting-edge medical solutions. This technology involves the insertion of DNA fragments from a variety of sources, having a desirable gene sequence via appropriate vector.
Our techniques of recombinant DNA technology, gene therapy, and genetic modifications are used for the purpose of bioremediation and for treating serious diseases. Owing to our tremendous advancements and broad range of application in the field of recombinant DNA technology we have further streamlined our processes in order to ensure most effective treatments for patient’s use.
Bio-Safety Testing:
At ABBEY MEDICAL SUPPLIES LIMITED medicals, our expert scientists and bioengineers carry out biosafety testing for sterility, Direct Inoculation (ep 2.6.1), Filtration method (ep 2.6.1), Alternative automatised method, Endotoxins detection (ep 2.6.14, USP), Cytotoxicity testing (iso 10993-5, USP), Pyrogen detection (ep 2.6.30, In vitrotesting), Bacterial identification, Vitek2, Apigallery, Virus testing (EP 2.6.16, 5.2.3, ICHQ5A), In vitro adventitious virus assays, Mycoplasma testing (ep 2.6.7, FDA), Cell banks and raw materials, Cell-derived harvests and final product, Viral seeds and harvests, Animal tissue and for cell-derived products.
We also conduct Purified drug substances testing for “PRP”, Supporting manufacture of biologicals and Recombinant protein. Biosafety testing on Monoclonal antibodies, Viral vaccines, Cell therapies and Gene therapy tests are also carried out by our expert teams.